Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy

This study has been completed.
Sponsor:
Collaborator:
Bayer
Information provided by:
Steno Diabetes Center
ClinicalTrials.gov Identifier:
NCT00311870
First received: April 4, 2006
Last updated: NA
Last verified: April 1999
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: April 1999
  Estimated Primary Completion Date: No date given
Publications: